ResearcherFondazione PisaActive in the last 2 years
Liam Andrew McDonnell
Matched on ORCID iD 0000-0003-0595-9491; OpenAlex author ID A5087234831. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2024: 2 papers · 2025: none · 2026: 2 papers
Papers 4
- CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2026.218851↗
- Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies Ribosomal Proteins Associated with Surv… Last author DOI 10.1021/acs.jproteome.6c00168↗
- Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells. Co-author DOI 10.1016/j.ijrobp.2023.10.035↗
- ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Co-author DOI 10.1186/s13046-023-02879-8↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisa Giovannetti · 4 shared papers, 2024–2026 · strength 1.03
- Paper CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. DOI 10.1016/j.canlet.2026.218851↗
- Paper Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies… DOI 10.1021/acs.jproteome.6c00168↗
- Paper Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cell… DOI 10.1016/j.ijrobp.2023.10.035↗
- Asia Botto · 2 shared papers, 2024–2026 · strength 0.51
- Paper Proteomics of Extracellular Vesicles Derived from Primary Cells of Pancreatic Ductal Adenocarcinoma Patients Identifies… DOI 10.1021/acs.jproteome.6c00168↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8↗
- Thomas Schmidt · 2 shared papers, 2024 · strength 0.36
- Paper Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cell… DOI 10.1016/j.ijrobp.2023.10.035↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8↗
- Erik H.J. Danen · 2 shared papers, 2024 · strength 0.36
- Paper Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cell… DOI 10.1016/j.ijrobp.2023.10.035↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8↗
- Cecilia Bergonzini · 2 shared papers, 2024 · strength 0.36
- Paper Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cell… DOI 10.1016/j.ijrobp.2023.10.035↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8↗
- Alessandro Gregori · 2 shared papers, 2024 · strength 0.36
- Paper Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cell… DOI 10.1016/j.ijrobp.2023.10.035↗
- Paper ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pan… DOI 10.1186/s13046-023-02879-8↗
- Annalisa Comandatore · 1 shared paper, 2026 · strength 0.33
- Mafalda Angelica Rocco · 1 shared paper, 2026 · strength 0.33
- Giulia Lencioni · 1 shared paper, 2026 · strength 0.33
- Luca Morelli · 1 shared paper, 2026 · strength 0.33
- Pei Pei · 1 shared paper, 2024 · strength 0.18
- Adam Enver Frampton · 1 shared paper, 2024 · strength 0.18
- Mjriam Capula · 1 shared paper, 2024 · strength 0.18
- Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.